Does mirabegron relieve ureteric stent‐related discomfort? A prospective, randomized, multicentre study

Abstract

The use of 50 mg mirabegron once daily has the potential to reduce ureteric stent-related discomfort. Prospective larger-scale, placebo-controlled studies are warranted to further evaluate the beneficial effects of mirabegron on stent-related symptoms.